161605-73-8,MFCD07364000
Catalog No.:AA001VNZ

161605-73-8 | Phosphonic acid, P-[[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo-6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
99%
1 week  
$222.00   $155.00
- +
10mg
99%
1 week  
$317.00   $222.00
- +
50mg
99%
1 week  
$1,177.00   $824.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001VNZ
Chemical Name:
Phosphonic acid, P-[[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo-6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]-
CAS Number:
161605-73-8
Molecular Formula:
C14H15F3N3O6P
Molecular Weight:
409.2544
MDL Number:
MFCD07364000
SMILES:
O=c1[nH]c2cc(c(cc2n(c1=O)CP(=O)(O)O)N1CCOCC1)C(F)(F)F
Properties
Properties
 
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
651  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.5  

Downstream Synthesis Route
Literature

Title: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

Journal: Journal of medicinal chemistry 20100812

Title: Effects of the AMPA antagonist ZK 200775 on visual function: a randomized controlled trial.

Journal: PloS one 20100101

Title: Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.

Journal: Neuroscience 20081028

Title: Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Journal: Psychopharmacology 20040801

Title: AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.

Journal: Stroke 20021201

Title: Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

Journal: Bioorganic & medicinal chemistry letters 20010507

Title: Turski L, et al. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10960-5.

Title: Kosowski AR, et al. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology (Berl). 2004 Aug;175(1):114-23.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 161605-73-8
Tags:161605-73-8 Molecular Formula|161605-73-8 MDL|161605-73-8 SMILES|161605-73-8 Phosphonic acid, P-[[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo-6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]-
Catalog No.: AA001VNZ
161605-73-8,MFCD07364000
161605-73-8 | Phosphonic acid, P-[[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo-6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]-
Pack Size: 5mg
Purity: 99%
1 week
$222.00 $155.00
Pack Size: 10mg
Purity: 99%
1 week
$317.00 $222.00
Pack Size: 50mg
Purity: 99%
1 week
$1,177.00 $824.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001VNZ
Chemical Name: Phosphonic acid, P-[[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo-6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]-
CAS Number: 161605-73-8
Molecular Formula: C14H15F3N3O6P
Molecular Weight: 409.2544
MDL Number: MFCD07364000
SMILES: O=c1[nH]c2cc(c(cc2n(c1=O)CP(=O)(O)O)N1CCOCC1)C(F)(F)F
Properties
Storage: Inert atmosphere;2-8℃;  
Complexity: 651  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 27  
Hydrogen Bond Acceptor Count: 10  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.5  
Downstream Synthesis Route
Literature fold

Title: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

Journal: Journal of medicinal chemistry20100812

Title: Effects of the AMPA antagonist ZK 200775 on visual function: a randomized controlled trial.

Journal: PloS one20100101

Title: Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.

Journal: Neuroscience20081028

Title: Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Journal: Psychopharmacology20040801

Title: AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.

Journal: Stroke20021201

Title: Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

Journal: Bioorganic & medicinal chemistry letters20010507

Title: Turski L, et al. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10960-5.

Title: Kosowski AR, et al. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology (Berl). 2004 Aug;175(1):114-23.

Building Blocks More >
165250-87-3
165250-87-3
4-(3-Aminophenoxy)benzoic acid
AA001VY3 | MFCD16620220
165670-57-5
165670-57-5
2H-Tetrazole, 2-(1-methyl-1-phenylethyl)-5-phenyl-
AA001W7Q | MFCD05996221
166196-84-5
166196-84-5
1-(2-Chloropyridin-3-yl)-3-(dimethylamino)prop-2-en-1-one
AA001WHR | MFCD00037942
16650-32-1
16650-32-1
5,8-Difluoroquinoline
AA001WPY | MFCD01939053
166964-33-6
166964-33-6
5-Chloro-3-methylbenzo[b]thiophene-2-sulfonyl chloride
AA001WZZ | MFCD00173797
167415-27-2
167415-27-2
4-Bromo-2,5-difluoronitrobenzene
AA001XAG | MFCD00042184
16780-04-4
16780-04-4
2-(3-Piperidyl)ethanol, HCl
AA001XJF | MFCD14583117
168268-00-6
168268-00-6
4-(Benzyloxy)-3-fluoroaniline
AA001XVL | MFCD08686866
1687-53-2
1687-53-2
5-Amino-2-methoxyphenol
AA001Y5J | MFCD00010222
169130-42-1
169130-42-1
6-BENZOFURANCARBOXYLIC ACID, 2,3-DIHYDRO-4-HYDROXY-2,2-DIMETHYL-
AA001YFO | MFCD11226226
Submit
© 2017 AA BLOCKS, INC. All rights reserved.